Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced Cancer.
第一作者:
Filip,Janku
第一单位:
Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. fjanku@me.com.
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);女(雌)性(Female);基因检测(Genetic Testing);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);人类(Humans);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);肿瘤(Neoplasms);预后(Prognosis);结果可重复性(Reproducibility of Results);敏感性与特异性(Sensitivity and Specificity)
DOI
10.1158/1078-0432.CCR-17-0291
PMID
28536309
发布时间
2018-11-13
- 浏览18
Clinical cancer research
5648-5656页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



